Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
12 /100
LOW RISK
Score updated Aug 28, 2026

NVS — Novartis AG Dilution Risk Tracker

Track NVS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NVS — Get alerts when the score changes →

As of August 28, 2026, Novartis AG (NVS) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Novartis AG has a market capitalization of $286.54B, 1.91B shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
10
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NVS.
🔔 Track NVS — Get forecast alerts →

Market Data

Market Cap$286.54B
Shares Outstanding1.91B
Float1.82B
Cash$6.89B
Debt$47.00B
Short InterestN/A

Institutional Holdings

7.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track NVS for full holder detail →

Short Interest

Short Interest5.24M
Days to Cover2.7
% of Float0.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track NVS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NVS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

HON AIG APTV BABAF CMCSA CPT DBD EE GM GTX

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NVS
NVS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.